Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
EHC 2022
AES 2022
WSC 2022
ECTRIMS 2022
EHDN 2022
MDS 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Amyotrophic Lateral Sclerosis
1:44
Unanswered questions in ALS research
Clive Svendsen
• 15 Mar 2022
1:32
Phase II and III studies of CNM-Au8 in ALS
Robert Glanzman
• 13 Oct 2021
3:23
Gene-based therapies for neurodegenerative & neuromuscular diseases
Aida Abu-Baker
• 11 Oct 2021
4:02
How does C9orf72 expansion impact protein degradation pathways in FTLD and ALS?
Annakaisa Haapasalo
• 16 Sep 2021
3:43
A novel genetic marker to detect C9orf72 repeat expansion carriers
Annakaisa Haapasalo
• 16 Sep 2021
3:03
Outcome measures in motor neuron diseases and neuropathies
Marianne de Visser
• 28 Sep 2021
3:26
Novel outcome measures for ALS and SMA
Marianne de Visser
• 28 Sep 2021
6:05
Using antibodies and intrabodies to target pathogenic TDP-43 in ALS
Neil Cashman
• 2 Aug 2021
2:11
MS research from EAN 2021
Massimo Filippi
• 17 Jun 2021
2:06
Collaboration between neurology and palliative care services in ALS
David Oliver
• 11 Jun 2021
4:46
Palliative care improves QoL in advanced neurodegenerative disorders
David Oliver
• 11 Jun 2021
3:40
AMX0035 in ALS: long-term survival analysis of the CENTAUR trial
Sabrina Paganoni
• 15 Apr 2021
0:56
A new era in the discovery of ALS treatments
Sabrina Paganoni
• 15 Apr 2021
3:11
CNM-Au8 gold nanocatalysts to slow disease progression in ALS
Robert Glanzman
• 1 Mar 2021
0:46
The perpetual multi-center multi-regimen Healy-ALS Platform trial
Robert Glanzman
• 1 Mar 2021
2:54
Debating controversies in ALS
Ettore Beghi
• 27 Oct 2020
Previous
1
2
3
Next